BONITA SPRINGS, Fla., May 16 — Optivate, a leading provider of specialty-built software and solutions for ophthalmology practices, today announced the appointment of Brad Caldwell as Chief Executive Officer. Abdiel Marin, the company’s Founder and CEO, will transition to a role as an advisor and remain on the Board of Directors as the company enters its next phase of growth.
Caldwell brings extensive experience in healthcare technology, go-to-market strategy, and operational leadership. As CEO, he will focus on scaling Optivate’s platform, strengthening customer outcomes, and accelerating innovation across its suite of solutions.
“I’m honored to step into the role of CEO at such a pivotal time for Optivate,” said Caldwell. “The company has built a strong foundation with a clear mission—helping ophthalmology practices cut through complexity and focus on delivering exceptional care. I’m excited to work alongside this talented team to further expand our impact and continue delivering meaningful value to our customers.”
Under Marin’s leadership, Optivate established itself as a trusted partner for eye care providers, delivering integrated solutions spanning electronic health records (EHR), practice management (PM), revenue cycle management (RCM), and patient engagement.
“Leading Optivate has been an incredibly rewarding journey,” said Marin. “I’m proud of what we’ve built and confident in Brad’s ability to take the company to the next level. I look forward to supporting the team in my continued role on the board and as a strategic advisor.”
Optivate delivers specialty-built software and solutions designed to simplify operations and empower care teams within ophthalmology practices. From EHR and PM to RCM and patient engagement, the company provides clarity that powers confident care. Built on best-in-class customer support and a long-standing dedication to eye care, Optivate is the partner of choice for providers seeking to remove friction, improve workflows, and elevate patient outcomes.
This leadership transition marks an important milestone as Optivate continues to expand its vision and deepen its commitment to the ophthalmology community.